Related Experiment Video
Updated: Jun 5, 2026

06:30
A Non-Coding Small RNA MicC Contributes to Virulence in Outer Membrane Proteins in Salmonella Enteritidis
Published on: January 27, 2021
A processed noncoding RNA regulates an altruistic bacterial antiviral system.
Tim R Blower1, Xue Y Pei, Francesca L Short
1Department of Biochemistry, University of Cambridge, Cambridge, UK.
Nature Structural & Molecular Biology
|January 18, 2011
Summary
Bacterial phage resistance involves a toxin (ToxN) and antitoxin (ToxI) system. Researchers elucidated the ToxN-ToxI complex structure, revealing RNA-protein interactions and ToxN’s endoRNase activity regulated by its product.
Area of Science:
- Microbiology
- Structural Biology
- Molecular Biology
Background:
- Bacteriophages drive bacterial evolution, necessitating phage-resistance mechanisms.
- The ToxIN system, comprising ToxN toxin and ToxI antitoxin, confers phage resistance.
- The precise mechanisms of ToxN toxicity and ToxI inhibition remain undefined.
Purpose of the Study:
- To determine the structural basis of the ToxN-ToxI complex.
- To elucidate the mechanism of phage resistance mediated by the ToxIN system.
Main Methods:
- X-ray crystallography was employed to determine the structure of the ToxN-ToxI complex.
- Structural analysis focused on RNA-protein interactions within the complex.
Main Results:
- The crystal structure of the ToxN-ToxI complex from Pectobacterium atrosepticum was determined at 2.75-Å resolution.
- A trimeric complex formed by three ToxI monomers and three ToxN monomers was observed.
- Extensive RNA-protein interactions mediate the assembly of the ToxN-ToxI complex.
- ToxN was identified as an endoRNase that processes ToxI, with regulation by its catalytic product.
Conclusions:
- The structure reveals intricate RNA-protein interactions critical for ToxIN system assembly.
- ToxN functions as an endoRNase, processing its own regulatory RNA antitoxin, ToxI.
- This provides mechanistic insight into bacterial phage resistance strategies.
Related Concept Videos
Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this defense.
Translational Regulation
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

